Functional characterization of coding polymorphisms in the human MDR1 gene using a vaccinia virus expression system

Area of Science:

• Pharmacogenomics
• Molecular Biology
• Cell Biology

Background:

• The human MDR1 gene encodes P-glycoprotein (P-gp), a transporter crucial for drug distribution and excretion.
• Polymorphisms in MDR1 may influence P-gp function and drug response.
• Understanding these variations is key to personalized medicine.

Purpose of the Study:

• To investigate the functional impact of common MDR1 coding polymorphisms on P-gp.
• To assess whether these genetic variations alter P-gp expression, localization, and substrate specificity.
• To evaluate the combined effects of common P-gp polymorphisms.

Main Methods:

• Utilized a vaccinia virus-based transient expression system to characterize five MDR1 coding polymorphisms (N21D, F103L, S400N, A893S, A998T).
• Assessed cell surface P-gp expression using monoclonal antibodies (MRK-16) and Western blotting (C219).
• Evaluated P-gp pump function and substrate specificity using various fluorescent MDR1 substrates (e.g., bodipy-FL-verapamil, calcein-AM) and transport assays.

Main Results:

• Cell surface expression of wild-type P-gp and its common polymorphisms showed similar time-dependent patterns.
• P-gp pump function was demonstrated for multiple substrates, with no substantial alteration in substrate specificity due to tested polymorphisms.
• Double mutants of common polymorphisms (N21D-S400N, N21D-A893S, S400N-A893S) exhibited no differences in expression or function compared to wild-type P-gp.

Conclusions:

• Common MDR1 coding polymorphisms do not significantly affect P-gp cell surface expression or function.
• These genetic variations do not alter the substrate specificity of the P-gp transporter.
• The functional impact of common P-gp polymorphisms on drug transport appears minimal.